Clene Nanomedicine Raises Series D Financing of $42.5 Million
SALT LAKE CITY, Aug. 26, 2020 /PRNewswire/ -- Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced that it has secured $42.5 million in a Series D…
SALT LAKE CITY, Aug. 26, 2020 /PRNewswire/ -- Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced that it has secured $42.5 million in a Series D…